Donor Human Stool: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Donor Human Stool. Educational only — not medical advice.
Labeled uses
REBYOTA is indicated for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibiotic treatment for recurrent CDI.
Source: FDA labeling via NIH DailyMed (set 7af8a7f6…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.